CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc.（CNSP）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CNSP · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
CNS Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CNSP 季度内部人买卖趋势
CNSP 内幕交易卖出 · CNSP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CNSP CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CNSP 高管卖出股份 · CNSP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | Charles Faith L. Director | Purchase | 7,100 | $34K | Form 4 |
| Aug 22, 2023 | Downs Christopher CFO | Purchase | 27,000 | $34K | Form 4 |
| Aug 16, 2023 | Climaco John M CEO · Director | Purchase | 2,750 | $5K | Form 4 |
| Dec 6, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $14K | Form 4 |
| Dec 7, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $14K | Form 4 |
| Dec 8, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $13K | Form 4 |
| Dec 9, 2022 | Priebe Waldemar 10 percent owner | Sale | 2,798 | $7K | Form 4 |
| Mar 10, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 13, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $7K | Form 4 |
| Mar 14, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $7K | Form 4 |
| Mar 15, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 16, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 17, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 20, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 21, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 22, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 23, 2023 | Priebe Waldemar 10 percent owner | Sale | 10,000 | $11K | Form 4 |
| Mar 24, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 27, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 28, 2023 | Priebe Waldemar 10 percent owner | Sale | 10,000 | $10K | Form 4 |
| Apr 28, 2023 | Climaco John M CEO · Director | Option | 1,250 | — | Form 4 |
| Apr 28, 2023 | Downs Christopher CFO | Option | 521 | — | Form 4 |
| Apr 19, 2023 | Gumulka Jerzy Director | Purchase | 2,500 | $4K | Form 4 |
| Apr 17, 2023 | Downs Christopher CFO | Purchase | 3,100 | $10K | Form 4 |
| Apr 10, 2023 | Gumulka Jerzy Director | Purchase | 7,173 | $5K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CNSP 内幕交易
CNSP 内幕交易
CNS Pharmaceuticals, Inc.（CNSP）内幕交易数据来源于公司内部人（包括Charles Faith L. (Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。CNSP内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看CNS Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CNSP 内幕交易 · 5个问题CNS Pharmaceuticals, Inc.（CNSP）的内部人包括高管和董事，如Charles Faith L. (Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026